CMLT

CM Life Sciences III (CMLT)

CM Life Sciences III Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CMLT

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/05/09	06 : 06	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CMLT	CM Life Sciences III Inc
2023/03/13	22 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CMLT	CM Life Sciences III Inc
2023/02/24	07 : 31	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:CMLT	CM Life Sciences III Inc
2023/02/24	07 : 30	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:CMLT	CM Life Sciences III Inc
2023/02/24	06 : 08	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:CMLT	CM Life Sciences III Inc
2023/02/23	21 : 09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CMLT	CM Life Sciences III Inc
2023/02/23	06 : 09	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:CMLT	CM Life Sciences III Inc
2023/02/23	06 : 06	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:CMLT	CM Life Sciences III Inc
2023/02/10	01 : 29	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CMLT	CM Life Sciences III Inc
2023/01/11	22 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CMLT	CM Life Sciences III Inc
2022/11/30	07 : 12	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:CMLT	CM Life Sciences III Inc
2022/11/26	06 : 08	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CMLT	CM Life Sciences III Inc
2022/11/26	06 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CMLT	CM Life Sciences III Inc
2022/11/14	20 : 10	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CMLT	CM Life Sciences III Inc
2022/11/11	06 : 37	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CMLT	CM Life Sciences III Inc
2022/11/10	21 : 10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CMLT	CM Life Sciences III Inc
2022/08/13	05 : 10	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:CMLT	CM Life Sciences III Inc
2022/08/13	05 : 07	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:CMLT	CM Life Sciences III Inc
2022/05/14	05 : 16	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CMLT	CM Life Sciences III Inc
2022/03/24	19 : 05	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:CMLT	CM Life Sciences III Inc
2022/03/24	05 : 44	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:CMLT	CM Life Sciences III Inc
2022/03/23	20 : 11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CMLT	CM Life Sciences III Inc
2022/03/02	08 : 29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CMLT	CM Life Sciences III Inc
2022/03/02	08 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CMLT	CM Life Sciences III Inc
2022/02/15	02 : 36	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CMLT	CM Life Sciences III Inc
2022/02/12	07 : 07	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CMLT	CM Life Sciences III Inc
2022/01/10	21 : 46	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CMLT	CM Life Sciences III Inc
2022/01/10	21 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CMLT	CM Life Sciences III Inc
2021/12/30	23 : 37	Edgar (US Regulatory)	Sec Staff Action/letter (sec Staff)	NASDAQ:CMLT	CM Life Sciences III Inc
2021/12/30	23 : 36	Edgar (US Regulatory)	Sec Staff Action/letter (sec Staff)	NASDAQ:CMLT	CM Life Sciences III Inc